unknown
Stage
About
Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted small-molecule kinase inhibitors and precision therapies for genomically defined cancers and rare diseases. The company advances clinical and preclinical programs focused on oncology and genetic disease indications.
Explore Blueprint Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.